729MO Circulating tumour (ct) DNA analysis of BRAF V600E dynamics and changes in genomic landscape in patients (pts) with first-line (1L) BRAF V600E-mutant metastatic colorectal cancer (mCRC) treated in BREAKWATER
S. Kopetz(The University of Texas MD Anderson Cancer Center), Keya Shah(Pfizer (United States)), T. Yoshino(National Cancer Center Hospital East), R. Yaeger(Memorial Sloan Kettering Cancer Center), C. Eng(Vanderbilt University), E. Van Cutsem(Universitair Ziekenhuis Leuven), Harpreet Wasan(Hammersmith Hospital), J. Desai(Peter MacCallum Cancer Centre), Fortunato Ciardiello(University of Campania "Luigi Vanvitelli"), Tim Maughan(University of Liverpool), T.W. Kim(Asan Medical Center), Seth A. Rosenthal(Pfizer (United States)), Maíra Saul(Pfizer (United States)), P. Hamilton(Pfizer (United States)), Xiu Juan Zhang(Pfizer (United States)), J. Tabernero(Vall d'Hebron Hospital Universitari)
Cited by 2
Abstract
Related Papers
No related papers found
Powered by citation graph analysis